Chemical UV Filters Detected in Human Breast Tissue — What the Research Shows

The question of where chemical sunscreen ingredients end up inside the human body has moved from theoretical concern to documented finding. A peer-reviewed study published in the Journal of Applied Toxicology in 2018 detected multiple chemical UV filter compounds in human breast tissue samples taken from women undergoing mastectomy, raising questions about the long-term fate of these ingredients after systemic absorption.

What Did the Study Find?

The research — Darbre et al., Journal of Applied Toxicology, 2018 — analysed breast tissue samples from 40 women who had undergone mastectomy. The tissue was tested for the presence of several UV filter compounds commonly found in sunscreens and other cosmetic products.

The results showed widespread detection across the sample group:

• Benzophenone-3 (BP-3 / oxybenzone) was detected in 69% of breast tissue samples

• Octyl methoxycinnamate (OMC / octinoxate) was detected in 74% of breast tissue samples

• 4-Methylbenzylidene camphor (4-MBC / enzacamene) was detected in 13% of breast tissue samples

The full study, available via Wiley Online Library, also reported a statistically significant finding regarding the distribution of BP-3 within the breast. Greater concentrations of BP-3 were measured in the lateral quadrant of the breast in samples where a tumour was present compared to those without a tumour (P=.007). The researchers cautioned that this finding does not establish a causal relationship — it is an association in a cross-sectional tissue study, and many factors could contribute to regional differences in compound accumulation.

How Do UV Filters Reach Breast Tissue?

The detection of UV filter compounds in breast tissue is consistent with the established finding — confirmed by the FDA's clinical trial (Matta et al., JAMA 2020) — that chemical UV filters are absorbed through the skin and enter systemic circulation. Once in the bloodstream, lipophilic (fat-soluble) compounds can accumulate in fatty tissues, including breast tissue, which has a high lipid content.

OMC and 4-MBC are both lipophilic molecules. Their detection in breast tissue at the frequencies observed by Darbre et al. suggests that the systemic absorption demonstrated in clinical studies does translate into measurable tissue accumulation in at least some individuals. The frequency of detection — particularly the 74% rate for OMC — is notable given the sample size of 40 participants.

Important Limitations to Note

Several important caveats apply to interpreting this study:

• Small sample size: The cohort of 40 women is relatively small for drawing population-level conclusions. Larger studies would be needed to confirm the frequency of detection across a broader and more diverse population.

• Cross-sectional design: The study captures a snapshot in time and cannot determine how long the compounds had been accumulating in the tissue, or what exposure routes contributed most.

• Mixed exposure sources: While sunscreen is a significant source of BP-3 and OMC exposure, these compounds are also used in other cosmetic products, hair care formulations, and plastics, making source attribution complex.

What UV Filters Were Tested and Why Does It Matter?

The three UV filters detected — BP-3 (oxybenzone), OMC (octinoxate), and 4-MBC — are all approved for use in Australian sunscreens under current TGA regulations. BP-3 and OMC are among the most widely used chemical UV filters globally. 4-MBC, as discussed in companion ASC articles, has since been banned in the European Union and deemed "not safe" by the UK Scientific Advisory Group on Cosmetic Safety.

The detection of these compounds in breast tissue — a hormonally sensitive tissue type — is particularly relevant given that several of these UV filters have been characterised in separate research as having oestrogenic or endocrine-disrupting properties. Darbre et al.'s tissue findings add a geographical dimension to that concern: the compounds are not simply passing through the body transiently but are accumulating at specific sites.

What Does This Mean for Sunscreen Users?

This is a tissue detection study in a small sample; it documents the presence of UV filter compounds but does not quantify any associated health risk. The study's significance lies in what it adds to the broader evidence picture: chemical UV filters applied to skin can, in at least some individuals, be detected in breast tissue.

For consumers who wish to minimise exposure to chemical UV filters, mineral-based sunscreens using zinc oxide or titanium dioxide as the active ingredient offer broad-spectrum UV protection without the systemic absorption profile documented for the chemical filters studied by Darbre et al.

ASC Guidance on Sun Protection

The Australian Sunscreen Council recognises that the most effective form of UV protection is physical protection: wearing sun-protective clothing, broad-brimmed hats, and UV-rated sunglasses. During peak UV times (typically 10 am to 3 pm in Australia), limiting direct sun exposure is the single most effective way to reduce UV-related skin damage.

At the same time, moderate sun exposure during early morning and late afternoon — when UV levels are lower — supports the body's natural production of vitamin D and nitric oxide, both of which play important roles in bone health, immune function, and cardiovascular health. Research published in Nature Scientific Reports (Hazell et al., 2023) has demonstrated that low-dose daylight exposure induces nitric oxide release in skin cells with negligible DNA damage, and the landmark Australian Sun-D Trial (British Journal of Dermatology, 2025) confirmed that daily high-SPF sunscreen use can increase risk of vitamin D deficiency.

Consumers who choose to use sunscreen should be aware of the ingredients in their products and consider mineral-based (zinc oxide and titanium dioxide) alternatives where possible. Always consult your doctor or dermatologist for personalised advice on sun protection, vitamin D status, and any concerns about specific sunscreen ingredients.

About the Australian Sunscreen Council

The Australian Sunscreen Council (ASC) is Australia's peak body for the sunscreen and SPF cosmetics industry. The ASC is made up of sunscreen manufacturers, brand owners, formulators, and raw-material suppliers committed to evidence-based sun safety. The Council's mission is not to push more sunscreen sales or position sunscreen as the sole solution to UV risk — it is to ensure that sunscreen fits into the broader health and UV protection picture, alongside physical protection, sensible sun exposure, and public education grounded in published science.

The ASC maintains an independent Scientific Advisory Committee whose members hold qualifications spanning topical and transdermal drug delivery (with U.S. FDA-funded regulatory research), occupational sun protection and skin cancer screening, paediatric and maternal sunscreen safety with over 30 years of research into chemical UV filter effects on pregnant women and children, toxicology with expertise in hazard identification and exposure-based risk assessment for topical products (BSc Biotechnology, MSc Analytical Bioscience, PhD Toxicology), and forensic ecotoxicology — including the scientific investigations that underpinned Hawaii's landmark reef-safe sunscreen legislation. Committee members hold triple board certifications (Canada, UK, USA) in relevant medical specialties and lead globally recognised research programmes.

The ASC exists to provide Australian consumers with access to the same peer-reviewed evidence that informs regulatory decisions in Europe, the United Kingdom, and the United States — so that individuals can make truly informed choices about how they protect themselves and their families from ultraviolet radiation.

For more information, visit australiansunscreencouncil.org.